120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
二维 PCR 同时检测粪便细菌标志物在炎症性肠病诊断和管理中的应用
Received 18 October 2025
Accepted for publication 24 January 2026
Published 4 February 2026 Volume 2026:19 566519
DOI https://doi.org/10.2147/JIR.S566519
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Nadia Andrea Andreani
Yueying Li, Hui Guo, Weiwei Liu
Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
Correspondence: Weiwei Liu, Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, People’s Republic of China, Tel +86-13162640870, Email huashanvivian@126.com
Background: Inflammatory bowel disease (IBD) is showing an increasing incidence in China, posing a significant threat to public health. IBD patients exhibit gut microbiota dysbiosis, and detection of IBD-associated gut microbes can aid in diagnosis and management.
Methods: We developed a 2D-PCR method based on base-quenching probe technology, which allowed closed-tube, single-tube simultaneous detection of four IBD-associated microbes: Ruminococcus gnavus, Veillonella spp. Ruminococcus torques, and Clostridioides difficile. Clinical fecal samples were tested including 224 IBD patients, 112 patients with other digestive diseases, and 57 healthy controls.
Results: The 2D-PCR method was demonstrated a detection limit of 10 copies/μL and no cross-reactivity between primers. The combination of R. gnavus and Veillonella spp. along with fecal occult blood test (FOBT), distinguished IBD patients from healthy controls (AUC = 0.9224, 95% CI [0.8747– 0.9701], p < 0.0001, Se = 85.11%, Sp = 92.59%) and IBD from other digestive diseases (AUC = 0.7984, 95% CI [0.7132– 0.8837], p < 0.0001, Se = 66.67%, Sp = 84.95%). R. torques was exclusively detected in Crohn’s disease patients (8.33% positivity), suggesting its potential as a specific diagnostic marker, albeit with limited sensitivity. C. difficile was detected in 8.93% of IBD patients and identifying such infections can guide antibiotic therapy and improve patient outcomes.
Conclusion: The 2D-PCR method is cost-effective and suitable for widespread clinical application with low technical and instrumental requirements. These detected microbial markers could aid in IBD diagnosis, differential diagnosis, and treatment guidance, serving as noninvasive biomarkers and expanding the clinical utility of gut microbiota in IBD management.
Keywords: inflammatory bowel disease, microbiology, PCR, molecular diagnostics
Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
Correspondence: Weiwei Liu, Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, 725 South Wanping Road, Shanghai, 200032, People’s Republic of China, Tel +86-13162640870, Email huashanvivian@126.com
Background: Inflammatory bowel disease (IBD) is showing an increasing incidence in China, posing a significant threat to public health. IBD patients exhibit gut microbiota dysbiosis, and detection of IBD-associated gut microbes can aid in diagnosis and management.
Methods: We developed a 2D-PCR method based on base-quenching probe technology, which allowed closed-tube, single-tube simultaneous detection of four IBD-associated microbes: Ruminococcus gnavus, Veillonella spp. Ruminococcus torques, and Clostridioides difficile. Clinical fecal samples were tested including 224 IBD patients, 112 patients with other digestive diseases, and 57 healthy controls.
Results: The 2D-PCR method was demonstrated a detection limit of 10 copies/μL and no cross-reactivity between primers. The combination of R. gnavus and Veillonella spp. along with fecal occult blood test (FOBT), distinguished IBD patients from healthy controls (AUC = 0.9224, 95% CI [0.8747– 0.9701], p < 0.0001, Se = 85.11%, Sp = 92.59%) and IBD from other digestive diseases (AUC = 0.7984, 95% CI [0.7132– 0.8837], p < 0.0001, Se = 66.67%, Sp = 84.95%). R. torques was exclusively detected in Crohn’s disease patients (8.33% positivity), suggesting its potential as a specific diagnostic marker, albeit with limited sensitivity. C. difficile was detected in 8.93% of IBD patients and identifying such infections can guide antibiotic therapy and improve patient outcomes.
Conclusion: The 2D-PCR method is cost-effective and suitable for widespread clinical application with low technical and instrumental requirements. These detected microbial markers could aid in IBD diagnosis, differential diagnosis, and treatment guidance, serving as noninvasive biomarkers and expanding the clinical utility of gut microbiota in IBD management.
Keywords: inflammatory bowel disease, microbiology, PCR, molecular diagnostics